There is little doubt that good work is good for you. Being in work meets important psychosocial needs in societies where employment is the norm; it helps build identity, provides structure to the day and companionship and is essential for material well-being and participation in society. Being in work is associated with better mental health and less frequent use of health services. In contrast, unemployment is bad for you. Unemployment, even in countries with a robust welfare system, results in poverty. 1 And poverty means people are unable to make life-style choices which maintain physical and emotional well-being. 2 This means that people with multiple sclerosis (MS) not only experience the consequences of the neurological impairment but are also, as identified by Landfeldt et al. 3 in this issue, at risk of chronic ill health from other conditions such as cerebrovascular disease and diabetes.
Unemployment is also expensive to the state. Landfeldt et al. 3 report that people with MS had a disability pension within 11 years of diagnosis. This is consistent with reports from other countries, and although there is some evidence, this is changing, it is doing so slowly. 4, 5 The obvious reason for high levels of unemployment is that people with MS are unemployed because of their disability. However, although it is true that people with MS who are unemployed have higher levels of disability than those who are not, the levels of disability do not themselves explain the job loss.
It has been known for some time that people with MS leave the work place shortly after diagnosis. There is growing evidence that the introduction of disease-modifying drugs (DMDs) has had an impact on employment rates in MS, with people on DMDs having higher employment rates than comparable groups not on DMDs. This might have led to a belief that as the disease is better treated, the numbers of people with MS who will need support will decrease. This may not be true for two reasons: first, people with MS continue to accrue disability albeit more slowly. But second, careful enquiry at diagnosis often elicits symptom-related work difficulties. The paper by Landfeldt et al. 3 highlights increased sick leave in the years prior to diagnosis. This means that by diagnosis, people are struggling at work, despite having little apparent disability.
What are the implications of this? The first is that the disability is often invisible and not captured by conventional measures. People are likely to leave work because of fatigue, anxiety and perceived attention and memory issues. These three symptoms can result in a vicious cycle where fatigue leads to attention difficulties and memory lapses, which feeds anxieties, which in turn aggravates both fatigue and anxiety.
Second, given fatigue, anxiety and attention and memory difficulties are the problem, vocational rehabilitation, that is, supporting people to remain in work, is a health issue. Good symptom management coupled with an understanding of the complex interplay between MS symptoms and other contextual factors is the domain of clinicians with experience of work-related interventions. Workplaces also need to be redesigned. There is evidence that people with disabilities are slow to take up work place adjustments and adaptations, perhaps fearing stigma. 6 More needs to be done to create disability-friendly work places, with peer support and disability champions. 7 Linking what happens in the neurology clinic to what happens in the work place is the domain of vocational rehabilitation, a process which enables persons with physical, cognitive and psychological impairments or health conditions to overcome obstacles to accessing, maintaining or returning to employment or other useful occupation. Vocational rehabilitation needs to be made available to all people with MS who need it. It has been shown to be effective and cost effective in many conditions, but there are particular challenges in demonstrating its effectiveness in a progressive condition where maintaining work is the desired outcome and where decreasing hours to maintain work stability may be a success. MS-specific work-related outcomes are useful in studies of MS but are less useful to policy planners who work across diagnostic groups. 8 Third, however services are organised, there is a clear need for clinicians who can not only make a diagnosis and treat the disease but also manage disability from diagnosis. It is tempting to believe that with the advent of DMDs, people with MS will need less support with managing disability or that rehabilitation services will only be needed once the disease becomes progressive. Rehabilitation and neurology services need to be integrated from diagnosis.
A further issue highlighted by this study is that with 10 years of diagnosis, 4 out of 10 people with MS had left work completely. This is similar to that found in other studies. Little is known about the processes by which people with MS leave the work place but anecdote would suggest that this is rarely carefully planned. Retiring 'well' means leaving work at an appropriate time, without regret, having identified other meaningful activities. Landfeldt et al. suggest that women may leave the work place earlier because of less interesting work or a greater burden at home. Another possibility is that men delay leaving work despite performance limitations. Women may leave work earlier than men with MS because they recognise growing performance limitations and can identify activities outside the workplace that they value.
In summary, work status in MS may be regarded as a proxy for comprehensive MS management that tackles relapse rates through the use of DMDs, supports excellent symptom management and knows how to modify environmental factors that impact the ability to work. Work is a health issue, and work status should be routinely recorded and regarded as a health outcome.
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